Race and Insurance Impact on Hospital Admission From the Emergency Department for Patients Diagnosed With Heart

Tammy Young1

  • 1Author Affiliation: Associate Vice President, Regulatory Services, University of Alabama at Birmingham.

Insights

Patient race and insurance status do not predict emergency department (ED) admission for congestive heart failure (CHF) patients. Recent ED visits and specific provider types significantly influenced CHF admission decisions.

Area of Science:

  • Health Services Research
  • Cardiology
  • Health Equity

Background:

  • High hospital readmission rates for congestive heart failure (CHF) indicate quality of care concerns.
  • Existing research has not comprehensively examined the interplay of patient race, insurance status, and quality metrics in predicting emergency department (ED) admissions for CHF.

Purpose of the Study:

  • To investigate whether patient race and insurance coverage influence the likelihood of emergency department (ED) admission for individuals diagnosed with congestive heart failure (CHF).
  • To identify key predictors of hospital admission for CHF patients presenting to the ED.

Main Methods:

  • Secondary data analysis utilizing cross-sectional archival data from the 2015 National Hospital Ambulatory Medical Care Survey.
  • Statistical methods included cross-tabulations with chi-squared tests, followed by multiple logistic regression analysis to assess predictive factors.

Main Results:

  • Neither patient race nor the presence of insurance was found to be a significant predictor of emergency department (ED) admission for patients diagnosed with congestive heart failure (CHF).
  • The study found no statistically significant association between race/insurance and CHF admission from the ED.

Conclusions:

  • Recent emergency department (ED) visits within 72 hours were a significant predictor of hospital admission for CHF.
  • Consultation with specific provider types, namely consulting physicians and nurse practitioners, was also significantly associated with increased odds of CHF admission.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
165
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
109
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
430
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
582
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
271
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K